| dc.contributor.author | Ahmed Sakr, Ayman | en_US |
| dc.contributor.author | Hanifi, Jasmine M. | en_US |
| dc.contributor.author | Valerie Lin, Ming | en_US |
| dc.date.accessioned | 2017-03-28T23:48:48Z | |
| dc.date.issued | 2017 | en_US |
| dc.identifier.citation | Ahmed Sakr, Ayman, Jasmine M. Hanifi, and Ming Valerie Lin. 2017. “Successful Treatment of Mixed Hepatitis C Genotypes in a Cirrhotic Patient With an All-Oral, Interferon-Free Regimen.” ACG Case Reports Journal 4 (1): e16. doi:10.14309/crj.2017.16. http://dx.doi.org/10.14309/crj.2017.16. | en |
| dc.identifier.issn | | en |
| dc.identifier.uri | http://nrs.harvard.edu/urn-3:HUL.InstRepos:31731699 | |
| dc.description.abstract | Mixed hepatitis C virus (HCV) genotype infection is emerging with improved methods of detection. It is commonly seen in hemodialysis patients and intravenous drug users due to repeated HCV exposure and absence of protective immunity, and can contribute to treatment failure. Direct-acting antiviral regimens have been extensively studied in patients with different individual HCV genotypes; however, there are no reported data on their use in patients with mixed HCV genotype. We present a case of mixed HCV genotype 1a and 2 infection in a decompensated cirrhotic patient treated successfully with sofosbuvir, ledipasvir, and ribavirin. | en |
| dc.language.iso | en_US | en |
| dc.publisher | American College of Gastroenterology | en |
| dc.relation.isversionof | doi:10.14309/crj.2017.16 | en |
| dc.relation.hasversion | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291715/pdf/ | en |
| dash.license | LAA | en_US |
| dc.title | Successful Treatment of Mixed Hepatitis C Genotypes in a Cirrhotic Patient With an All-Oral, Interferon-Free Regimen | en |
| dc.type | Journal Article | en_US |
| dc.description.version | Version of Record | en |
| dc.relation.journal | ACG Case Reports Journal | en |
| dc.date.available | 2017-03-28T23:48:48Z | |
| dc.identifier.doi | 10.14309/crj.2017.16 | * |
